Please login to the form below
Bill Gates
This page shows the latest Bill Gates news and features for those working in and with pharma, biotech and healthcare.
Gates MRI and Calibr announce licensing agreement for tuberculosis treatment
The Bill &Melinda Gates Medical Research Institute (GATES MRI) and Calibr, a division of Scripps Research, have announced a licensing agreement to advance an investigational compound to treat tuberculosis (TB). ... The discovery and preclinical studies
Latest news
-
Act-Accelerator outlines plans for longterm COVID-19 control
Set up in 2020, ACT-A was launched by the World Health Organization (WHO), the President of France, the President of the European Commission and the Bill &Melinda Gates Foundation, in
-
Merck and Bill & Melinda Gates Institute sign licensing agreement for tuberculosis candidates
Merck &Co – known as MSD outside the US and Canada – and the Bill &Melinda Gates Medical Research Institute (Gates MRI) have announced a licensing agreement for two preclinical tuberculosis (TB) antibiotic ... The two novel compounds discovered by
-
Bill & Melinda Gates Foundation commit $1.2bn as part of efforts to end polio worldwide
The Bill &Melinda Gates Foundation (the Foundation) has revealed it will commit $1.2bn to bolster efforts to end all forms of polio worldwide. ... Commenting on the need for further action against polio, Bill Gates, co-chair of the Bill &Melinda Gates
-
Manus Bio awarded $2m by Bill & Melinda Gates Foundation to combat malaria
Manus Bio has received a fourth award of $2m from the Bill &Melinda Gates Foundation to accelerate the development of a scalable and cost-effective production route for artemisinin, a key ... Commenting on the additional funding, Dr Christine Santos,
-
New Pfizer initiative, ‘An Accord for a Healthier World’, launched to improve global health equity
With funding from the Bill &Melinda Gates Foundation, Pfizer is working to develop vaccine candidates for Group B Streptococcus, a leading cause of stillbirth and newborn mortality in low-income countries. ... Bill Gates, Co-Chair of the Bill &Melinda
More from news
Approximately 1 fully matching, plus 79 partially matching documents found.
Latest Intelligence
-
Rethinking our approach to infectious disease preparedness
Bill Gates made this point long before COVID-19 emerged from Wuhan. ... We’re not ready’. Gates said: “Today, the greatest risk of global catastrophe.
-
Exploiting the value of data in pharma
The value of data collaboration. In March this year, the Bill &Melinda Gates Foundation launched an initiative called the COVID-19 Therapeutics Accelerator philanthropically bringing together a consortium of 15 of
-
Working together against COVID-19
Recently the Bill and Melinda Gates Foundation brought together an ‘unprecedented’ coronavirus partnership with the industry.
-
Pharma deals during May 2013
In Japan six local companies are contributing, along with the Bill and Melinda Gates Foundation, $100m for development of treatments for diseases prevalent in the developing world.
-
Interview: Charles Mgone, EDCTP
In the case of HIV, we're working with IAVI [International AIDS Vaccine Initiative] and the Bill and Melinda Gates Foundation. ... For instance, with the Gates Foundation we put funds together to support capacity to conduct clinical trials.
More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest appointments
-
Syneos Health Communications announces senior hires to Europe-based team
She has previously led global campaigns for the World Health Organisation, The Global Fund, IFPMA, The Bill and Melinda Gates Foundation and the ABPI.
-
Dan Carucci becomes global chief medical officer of McCann Health
Previously, he was appointed as the first director of the Grand Challenges in Global Health Initiative, a programme for the Bill &Melinda Gates Foundation.
-
Dr Keith Bragman joins Alacrita
Dr Bragman brings a wealth of industry experience to the firm, having served on the Science and Technology Select Committee at the House of Commons, worked with the Bill and Melinda ... Gates Foundation and at the UK government's department for
-
Cello Health Insight bolsters senior team
She brings 13 years of experience in quantitative research to the role, and has spent the last few years focused on public sector market research for the Bill &Melinda Gates Foundation.
-
Gary Nabel to lead Sanofi's strategy council
He succeeds Dr Richard Klausner, a former executive director for Global Health of the Bill and Melinda Gates Foundation, who led the council since March 2011. ... His predecessor as SDSAC chair Dr Klausner, in addition to his work at the Bill and Melinda
More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest from PMHub
-
Is communication killing the COVID-19 vaccine’s chance at success?
But waiting, just in the wings, were social media’s keyboard warriors, dangerously armed with anti-vaccination misinformation and carefully crafted theories about Bill Gates’ plan to steal our data with
-
Secondary effects of COVID-19 on the healthcare system and patients
By now, your social media feeds are probably full of COVID-19-related news articles, opinion pieces, and memes (not to mention conspiracy theories involving 5G or Bill Gates).
-
How to measure marketing success: profit vs ROI
Although Bill Gates is worth $86.4bn, he defines his success as making the personal computer commonplace in the home rather than the billions of dollars he earned in doing so,
-
Maria Eletskaya joins Cello Health Insight
She is a trained psychologist and for the last years she has been focused on public sector market research for the Bill &Melinda Gates Foundation.
-
A better future, or too ambitious to be true?
With so many leading organisations involved, including the Bill and Melinda Gates Foundation, perhaps we just might.
More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.
Subscribe to our email news alerts
-
Pharmacovigilance Project Lead
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Pharmacovigilance Manager
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
- MHRA to introduce new UK clinical trials framework
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- 2023 PM Society Awards – winners announced
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
- Critical success factors and the increasing value of rare disease clinical trials
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- Amgen gets block on sales of Repatha rival in Germany
- Congress is in session – how companies are boosting their impact and engagement
- The state of pharma customer experience
PMHub
Empowering Strategic Performance Ltd
OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
